Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [128]
The cited source says what the claim attributes to it.
In the citing paper
“a subset of CD4+ T cells that is a major contributor to the pathogenicity of several inflammatory and autoimmune conditions (9–11)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“inflammatory subtypes of T cells, particularly Th17 cells, are clearly deleterious in diseases such as multiple sclerosis (9–11, 24)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Th17 cells are deleterious to the CNS”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259
Self-citationExpression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes
Chung, Y., Yang, X., Chang, S. H., Ma, L., Tian, Q., & Dong, C. (2006) · Cell Research · doi:10.1038/sj.cr.7310106 · Cited by 231
Cited by
Items 501–600 of 1,003
Jin, S., Sonobe, Y., Kawanokuchi, J., Horiuchi, H., Cheng, Y. H., Wang, Y., Mizuno, T., Takeuchi, H., & Suzumura, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115981 · Cited by 68
Current perspectives on the role of IL-17 in autoimmune disease
Yamada, H. (2010) · Journal of Inflammation Research · doi:10.2147/jir.s6375 · Cited by 72
“In the central nervous system, IL-17 was shown to disrupt the blood-brain barrier tight junction, which facilitated local migration of CD4 T cells.(14) All these findings suggest an involvement of IL-17 in the pathogenesis of various autoimmune diseases”
Proinflammatory T Cell Status Associated with Early Life Adversity
Elwenspoek, M. M. C., Hengesch, X., Leenen, F. A. D., Schritz, A., Sias, K., Schaan, V., Mériaux, S. B., Schmitz, S., Bonnemberger, F., Schächinger, H., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701082 · Cited by 71
“tion, autoimmunity, and inflammation and promotes CNS inflammation by disruption of the blood–brain barrier (75).”
BackgroundCD44 Deficiency Contributes to Enhanced Experimental Autoimmune Encephalomyelitis
Flynn, K. M., Michaud, M., & Madri, J. A. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.003 · Cited by 70
Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin
Anderson, G., & Rodriguez, M. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03257.x · Cited by 62
“meability [51].”
Hiremath, G. S., Cettomai, D., Baynes, M., Ratchford, J. N., Newsome, S. D., Harrison, D. M., Kerr, D. A., Greenberg, B. M., & Calabresi, P. A. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509102844 · Cited by 70
“which have been suggested to be pathogenic in autoimmune conditions including MS [26,27].”
BackgroundYi, H., Bai, Y., Zhu, X., Lin, L., Zhao, L., Wu, X., Buch, S. J., Wang, L., Chao, J., & Yao, H. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9553-1 · Cited by 71
Saha, A., Sarkar, C., Singh, S. P., Zhang, Z., Munasinghe, J., Peng, S., Chandra, G., Kong, E., & Mukherjee, A. B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds038 · Cited by 63
“While TH17 lymphocytes have been implicated in mediating BBB disruption and neuroinflammation (4), the molecular mechanism(s), until now, remain unclear.”
BackgroundInfluentialIL-11 Induces Th17 Cell Responses in Patients with Early Relapsing-Remitting Multiple Sclerosis
Zhang, X., Tao, Y., Chopra, M., Dujmović, I., Jin, J., Tang, Y., Drulovic, J. S., & Markovic‐Plese, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401680 · Cited by 62
“and lymphocytes to the sites of inflammation (13).”
BackgroundThe role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders
Osborne, L. M., Brar, A., & Klein, S. L. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.015 · Cited by 73
Dhaeze, T., Tremblay, L., Lachance, C., Peelen, E., Zandee, S., Grasmuck, C., Bourbonnière, L., Larouche, S., Ayrignac, X., Rébillard, R., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0198-5 · Cited by 64
Self-citationMarín-Prida, J., Pavón-Fuentes, N., Llópiz-Arzuaga, A., Fernández-Massó, J. R., Delgado-Roche, L., Mendoza-Marí, Y., Santana, S. P., Cruz-Ramírez, A., Valenzuela-Silva, C., Nazábal-Gálvez, M., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.021 · Cited by 61
“, 2009), possibly mediated, at least partially, by BBB impairment (Kebir et al., 2007).”
BackgroundInvolvement of IL-17 in Secondary Brain Injury After a Traumatic Brain Injury in Rats
Tan, L., Zhang, Y., Han, D., Hua, R., Guo, B., Hu, S.-Q., Yan, X., & Xu, T. J. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8468-4 · Cited by 63
“Many studies have reported that IL-17 plays an important role in many nervous system diseases, such as the experimental autoimmune encephalomyelitis (EAE), Alzheimer’s disease and acute stroke (Kebir et al. 2007).”
BackgroundMicrobiota-immune interactions: from gut to brain
Salvo‐Romero, E., Stokes, P., & Gareau, M. G. (2020) · LymphoSign Journal · doi:10.14785/lymphosign-2019-0018 · Cited by 73
Mousavi-Shirazi-Fard, Z., Mazloom, Z., Izadi, S., & Fararouei, M. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1750398 · Cited by 68
“It has been stated that the expression of IL-17 receptor is enhanced in the brain endothelium in MS, thereby increasing inflammation [41].”
BackgroundGut microbiome and the risk factors in central nervous system autoimmunity
Ochoa-Repáraz, J., & Kasper, L. H. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.024 · Cited by 62
“to the vessels of healthy individuals [95].”
Begum-Haque, S., Sharma, A., Kasper, I. R., Foureau, D., Mielcarz, D. W., Haque, A., & Kasper, L. H. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.07.018 · Cited by 67
“, 2006) and in patients with multiple sclerosis (Kebir et al., 2007).”
Peelen, E., Damoiseaux, J. G. M. C., Smolders, J., Knippenberg, S. A. M., Menheere, P. P. C. A., Tervaert, J. W. C., Hupperts, R., & Thewissen, M. M. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.09.013 · Cited by 61
Frisullo, G., Nociti, V., Iorio, R., Patanella, A. K., Marti, A., Caggiula, M., Mirabella, M., Tonali, P. A., & Batocchi, A. P. (2008) · Cytokine · doi:10.1016/j.cyto.2008.08.007 · Cited by 83
“Gene microarray analysis of MS plaques revealed increased levels of IL17 transcript [13] and IL17 and IL22 producing CD445RO T cells were found in MS plaques [14].”
BackgroundResultInfluentialInfluence of the Gut Microbiome on Autoimmunity in the Central Nervous System
Colpitts, S. L., & Kasper, L. H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601438 · Cited by 66
“(26) showed that IL-17 receptor expression was upregulated in MS lesions, allowing IL-17 to increase the permeability of the BBB and promote migration of CD4 lymphocytes into the CNS.”
BackgroundImpact of aging immune system on neurodegeneration and potential immunotherapies
Liang, Z., Zhao, Y., Ruan, L., Zhu, L., Jin, K., Zhuge, Q., Su, D., & Zhao, Y. L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.006 · Cited by 67
“…into the CNS. Th17 secreted cytokines IL-17 and IL-22 bind and activate IL-17 and IL-22 receptors present on the BBB endothelium, leading to its disruption and permeabilization of BBB (Kebir et al., 2007), and the subsequent inflammation driven destruction of myelin and eventually axons.”
InfluentialWestern lifestyle and immunopathology of multiple sclerosis
Matveeva, O., Bogie, J. F. J., Hendriks, J. J. A., Linker, R. A., Haghikia, A., & Kleinewietfeld, M. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13583 · Cited by 76
Targeting the Adaptive Immune System in Depression: Focus on T Helper 17 Cells
Beurel, E., Medina-Rodriguez, E. M., & Jope, R. S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000256 · Cited by 64
“Th17 cells disrupt the blood brain barrier by acting on endothelial cells (Kebir et al., 2007), whereas they promote the production of cytokines by microglia (Murphy et al., 2010).”
BackgroundShi, C., Zhang, J., Wang, H., Chen, C., Han, M., Gao, L., Tang, C., Sun, P., Zhao, X., Guo, F., et al. (2022) · Advanced Materials · doi:10.1002/adma.202210262 · Cited by 66
Immunopathology in ocular toxoplasmosis: facts and clues
Garweg, J. G., & Candolfi, E. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000200014 · Cited by 62
“These cells also express high levels of granzyme B, can destroy human neurones and can promote inflammation of the central nervous system via recruitment of CD4(+) lymphocytes (Kebir et al. 2007).”
BackgroundAdvances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis
Volpe, E., Battistini, L., & Borsellino, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/475158 · Cited by 70
“Once in the brain parenchyma,Th17 cells release several proinflammatory mediators including IL-17A, responsible for the downregulation of tight junction proteins of the BBB, increasing BBB permeability, and favoring migration of both soluble inflammatory molecules and other circulating immune cells into the CNS [126].”
BackgroundInfluentialZhang, T., Fang, S., Wan, C., Kong, Q., Wang, G., Wang, S., Zhang, H., Zou, H., Sun, B., Sun, W., et al. (2015) · Scientific Reports · doi:10.1038/srep16548 · Cited by 61
A review on nanotechnology based innovations in diagnosis and treatment of multiple sclerosis
Ojha, S., & Kumar, B. (2017) · Journal of Cellular Immunotherapy · doi:10.1016/j.jocit.2017.12.001 · Cited by 63
Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets
Ghanaatian, N., Lashgari, N., Abdolghaffari, A. H., Rajaee, S. M., Panahi, Y., Barreto, G. E., Butler, A. E., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27965 · Cited by 61
Duan, H., Xing, S., Luo, Y., Feng, L., Gramaglia, I., Zhang, Y., Lu, D., Zeng, Q., Fan, K., Feng, J., et al. (2013) · Scientific Reports · doi:10.1038/srep01687 · Cited by 59
Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation
Derkow, K., Krüger, C., Dembny, P., & Lehnardt, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135898 · Cited by 67
“Quantification of CNS cells in vitro Viability of neurons was analyzed by quantifying NeuN+ cells in 6 to 8 fields (at 60x magnification) per cover slip, and the mean was calculated.”
BackgroundInfluentialZhao, X., Xu, L., Lu, S., & Huang, X. (2011) · European Journal of Immunology · doi:10.1002/eji.201040793 · Cited by 61
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041212 · Cited by 60
“CD4+ T cell dysregulation has a major role in MS pathogenesis by aggravating axonal and neuronal damage [1,161].”
BackgroundHopkins, E. G. D., Roumeliotis, T. I., Mullineaux-Sanders, C., Choudhary, J. S., & Frankel, G. M. (2019) · mBio · doi:10.1128/mbio.00062-19 · Cited by 70
“However, while Tsai and colleagues have shown upregulation of Claudin-2 at 2 DPI (20), which was found in higher abundance in the 4 DPI proteome than at other times, none of the responses measured in this study were induced at 3 DPI, correlating with the absence of visible C. rodentium in the colon at this time point.”
β1-Integrin– and KV1.3 channel–dependent signaling stimulates glutamate release from Th17 cells
Birkner, K., Wasser, B., Ruck, T., Thalman, C., Luchtman, D. W., Pape, K., Schmaul, S., Bitar, L., Krämer‐Albers, E., Stroh, A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126381 · Cited by 64
Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer
Bellone, M., Brevi, A., & Huber, S. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-19 · Cited by 65
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
Dziedzic, A., Saluk, J., Miller, E. D., & Bijak, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175957 · Cited by 65
“The secretion of IL-17 from infiltrating T cells into the CNS is associated with blood–brain barrier (BBB) disruption [51].”
BackgroundRegulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
Verreycken, J., Baeten, P., & Broux, B. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2153534 · Cited by 65
“It is also involved in BBB disruption and CNS inflammation.(35) All of these cell types cause an inflammatory cascade in the CNS by releasing chemokines”
BackgroundShi, G., Ramaswamy, M., Vistica, B. P., Cox, C. A., Tan, C., Wawrousek, E. F., Siegel, R. M., & Gery, I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900519 · Cited by 66
Harris, K. M., Fasano, A., & Mann, D. L. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.01.003 · Cited by 68
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis
Sato, D. K., Nakashima, I., Bar‐Or, A., Misu, T., Suzuki, C., Nishiyama, S., Kuroda, H., Fujihara, K., & Aoki, M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.01.008 · Cited by 58
“, 2005); they are found in MS lesions and can promote neuronal damage and blood–brain barrier disruption (Kebir et al., 2007; Montes et al., 2009).”
BackgroundComparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis
Fang, Y., Yu, S., Ellis, J. S., Sharav, T., & Braley‐Mullen, H. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0509352 · Cited by 59
“tis, and psoriasis in humans [4–6], as well as in animal models”
BackgroundBonnamain, V., Neveu, I., & Naveilhan, P. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00017 · Cited by 58
Menaceur, C., Gosselet, F., Fénart, L., & Saint‐Pol, J. (2021) · Cells · doi:10.3390/cells11010133 · Cited by 67
Mukhara, D., Oh, U., & Neigh, G. N. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00017-5 · Cited by 69
Eshraghi, R. S., Davies, C., Iyengar, R., Perez, L., Mittal, R., & Eshraghi, A. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010027 · Cited by 62
Kira, J. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.08.043 · Cited by 60
“Contrarily, Ito et al. [82] reported that multiple patchy enhancing lesions with blurred margins, described as “cloud-like enhancement”, are found in 90% of NMOpatients with contrast enhancement, suggesting breakdown of the BBB in this condition.”
BackgroundInfluentialThe Contribution of γδ T Cells to the Pathogenesis of EAE and MS
Blink, S. E., & Miller, S. D. (2009) · Current Molecular Medicine · doi:10.2174/156652409787314516 · Cited by 57
Bridge Between Neuroimmunity and Traumatic Brain Injury
Kelso, M. L., & Gendelman, H. E. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113196660653 · Cited by 60
Role of Cytokines and Toll-Like Receptors in the Immunopathogenesis of Guillain-Barré Syndrome
Nyati, K. K., & Prasad, K. N. (2014) · Mediators of Inflammation · doi:10.1155/2014/758639 · Cited by 59
“In parallel, activated T cell releases cytokines, helps B cells to produce antibodies that cross damaged blood-nerve barrier (BNB), engages unidentified epitopes on abaxonal Schwann cell surface, fixes complement, damages Schwann cell, and produces vesicular dissolution of myelin.”
BackgroundInfluentialPeripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis
Zeni‐Graiff, M., Rizzo, L. B., Mansur, R. B., Maurya, P. K., Sethi, S., da Cunha, G. R., Asevedo, E. D. M., Pan, P. M., Zugman, A., Yamagata, A. S., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.031 · Cited by 64
Imbalance between the anti- and pro-inflammatory milieu in blood leukocytes of autistic children
Ahmad, S. F., Nadeem, A., Ansari, M. A., Bakheet, S. A., Attia, S. M., Zoheir, K. M. A., AL-Ayadhi, L. Y., Alzahrani, M. Z., Alsaad, A. M. S., Alotaibi, M. R., et al. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.12.019 · Cited by 60
Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases
Joshi, A. U., & Mochly‐Rosen, D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.010 · Cited by 58
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia
Kerchner, G. A., Tartaglia, M. C., & Boxer, A. L. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.6 · Cited by 59
Cutforth, T., DeMille, M. M., Agalliu, I., & Agalliu, D. (2016) · Future Neurology · doi:10.2217/fnl.16.4 · Cited by 55
Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity
Chen, Y., Chauhan, S. K., Tan, X., & Dana, R. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.11.003 · Cited by 58
Ghadiri, N., Emamnia, N., Ganjalıkhani-Hakemi, M., Ghaedi, K., Etemadifar, M., Salehi, M., Shirzad, H., & Nasr‐Esfahani, M. H. (2018) · Gene · doi:10.1016/j.gene.2018.03.035 · Cited by 56
“Similar to the other autoimmune diseases, MS is neatly related to deficiencies in immune regulation through suppression of regulatory T cells (Treg) (Kebir et al., 2007) as their differentiation occurs through activation of STAT5/Foxp3 (Bartel, 2009).”
BackgroundThe interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis
Angelini, G., Bani, A., Constantin, G., & Rossi, B. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1101379 · Cited by 66
“In agreement with these data, both IL-17 and IL-22 can boost Th cell transmigration across brain endothelium in vitro, although IL-17 is more effective in inducing the production of endothelial proinflammatory molecules (Kebir et al., 2007; Wojkowska et al., 2017).”
BackgroundThe Role of Neuroinflammation and Network Anomalies in Drug-Resistant Epilepsy
Shi, J., Xie, J., Li, Z., He, X., Wei, P., Sander, J. W. A. S., & Zhao, G. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01348-w · Cited by 60
“Neurons can directly interact with CD4+ T cells, leading to the differentiation and proliferation of Th1 and Th17 cell subgroups [100].”
Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis
Toubi, E., Nussbaum, S., Staun-Ram, E., Snir, A., Melamed, D., Hayardeny, L., & Miller, A. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.003 · Cited by 61
“…however, recent studies have demonstrated the involvement of other immune cells such as CD8+, Th17, T regulatory cells (Tregs), monocytes, and B cells in the disease pathogenesis (Babbe et al., 2000; Crawford et al., 2004; de Andres et al., 2007; Kebir et al., 2007; Hedegaard et al., 2008).”
BackgroundSchiavone, S., Mhillaj, E., Neri, M., Morgese, M. G., Tucci, P., Bove, M., Valentino, M., Di Giovanni, G., Pomara, C., Turillazzi, E., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9791-8 · Cited by 55
“In order to investigate whether BBB integrity was affected by 1 week of social isolation, we performedWestern blot analysis for specific markers of BBB disruption that included MMP9, MMP2, occludin 1 [31], and PV-1 [32].”
Feng, Y., He, X., Luo, S., Chen, X., Long, S., Liang, F., Shi, T., Pei, Z., & Li, Q. (2018) · Brain Research · doi:10.1016/j.brainres.2018.11.019 · Cited by 58
Zhang, Y., Wang, X., Yang, X., Yang, X., Xue, J., & Yang, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c06304 · Cited by 58
Severson, C., & Hafler, D. A. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_12 · Cited by 62
Petracco, G., Faimann, I., & Reichmann, F. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108831 · Cited by 64
Zaffaroni, M., Marino, F., Bombelli, R., Rasini, E., Monti, M., Ferrari, M., Ghezzi, A., Comı, G., Lecchini, S., & Cosentino, M. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.08.015 · Cited by 54
Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis
Koch, M. W., Metz, L. M., & Kovalchuk, O. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.008 · Cited by 62
Pacheco, R., Riquelme, E., & Kalergis, A. (2010) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152410790780154 · Cited by 55
“For instance, 4integrins/VCAM-1 [73] and CXCR3/CXCL-9,-10 or -11 [74], LFA-1/ICAM-1 [75], CCR2/MCP-1 (exclusive for Th2 cells) [75], IL-22/IL-22R and IL-17/IL-17R (exclusive for Th17 cells) [76] mediate interactions of T cell/BBB respectively facilitating entrance of T cells into the CNS.”
BackgroundImmunopathology alters Th17 cell glucocorticoid sensitivity
Banuelos, J., Cao, Y., Shin, S. C., & Lu, N. Z. (2016) · Allergy · doi:10.1111/all.13051 · Cited by 58
“IL-17A and IL-6 are among the most highly expressed genes in brain lesions (75), and IL-17A is elevated in serum and cerebrospinal fluid of multiple sclerosis patients (76, 105).”
BackgroundHuo, W., Liu, Y., Lei, Y., Zhang, Y., Huang, Y., Mao, Y., Wang, C., Sun, Y., Zhang, W., Ma, Z., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.024 · Cited by 59
Multiple sclerosis: immunopathogenesis and controversies in defining the cause
Holmøy, T., & Hestvik, A. L. K. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f88b48 · Cited by 70
Th17 Cells and IL-17A in Ischemic Stroke
Wang, J., Gao, Y., Yuan, Y., Wang, H., Wang, Z., & Zhang, X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03723-y · Cited by 59
“Th17 cells and IL-17A are involved in BBB destruction in multiple sclerosis (MS) and autoimmune encephalomyelitis (EAE) disease models [50], and it is reasonable to suspect that IL-17-producing cells also contribute to BBB dysfunction after stroke (Fig.”
BackgroundGroß, C. C., Schulte‐Mecklenbeck, A., Steinberg, O. V., Wirth, T., Lauks, S., Bittner, S., Schindler, P., Baranzini, S. E., Groppa, S., Bellmann–Strobl, J., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.ade8560 · Cited by 58
Targeting cytokine networks in neuroinflammatory diseases
Becher, B., Derfuss, T. J., & Liblau, R. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01026-y · Cited by 60
Self-citationKjølhede, T., Dalgas, U., Gade, A. B., Bjerre, M., Stenager, E., Petersen, T., & Vissing, K. (2015) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12504 · Cited by 60
“In particular, IL-17 may constitute an excessive driver of proinflammatory cytokine expression and chronic CNS inflammation and lesion formation (Kebir et al., 2007).”
BackgroundLaaksonen, H., Guerreiro‐Cacais, A. O., Adzemovic, M. Z., Parsa, R., Zeitelhofer, M., Jagodic, M., & Olsson, T. P. (2014) · Genes and Immunity · doi:10.1038/gene.2014.36 · Cited by 58
The Interleukin 17 System in Cortical Lesions in Focal Cortical Dysplasias
He, J., Li, S., Shu, H., Yu, S., Liu, S., Yin, Q., & Yang, H. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318281262e · Cited by 56
“Indeed, Kebir et al (44) demonstrated that IL-17 promotes BBB disruption via binding with IL-17R in human endothelial cells.”
BackgroundInfluentialRole of CD4 + Cytotoxic T Lymphocytes in the Control of Viral Diseases and Cancer
Martorelli, D., Muraro, E., Merlo, A., Turrini, R., Rosato, A., & Dolcetti, R. (2010) · International Reviews of Immunology · doi:10.3109/08830185.2010.489658 · Cited by 64
“Differently, Kebir and colleagues described the in vitro generation of human CD4+CD45RO+Th17 from peripheral blood CD4+ lymphocytes cultured with IL-23, which expressed GrB (but not GrA and perforin) and a considerable cytolytic activity compared to unactivated T lymphocytes [51].”
Backgroundγδ T Cells Contribute to Injury in the Developing Brain
Albertsson, A.-M., Zhang, X., Vontell, R., Bi, D., Bronson, R. T., Supramaniam, V. G., Baburamani, A. A., Hua, S., Nazmi, A., Cardell, S., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.11.012 · Cited by 56
Yang, Z., & Yuan, C.-X. (2018) · BMC Anesthesiology · doi:10.1186/s12871-018-0607-4 · Cited by 53
“in the blood-brain barrier endothelial cells (BBB-ECs) from multiple sclerosis (MS) lesions, whereas IL-17 receptor inhibitor significantly alleviated the inflammation damage of central nervous system, which suggested that the brain damage of MS patients was related to the involvement of IL-17 [16].”
de Retana, S. F., Marazuela, P., Solé, M., Colell, G., Bonaterra, A., Sánchez-Quesada, J. L., Montaner, J., Maspoch, D., Cano-Sarabia, M., & Hernández-Guillamon, M. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0498-8 · Cited by 52
IL17A impairs blood–testis barrier integrity and induces testicular inflammation
Pérez, C. V., Pellizzari, E. H., Cigorraga, S. B., Galardo, M. N., Naito, M., Lustig, L., & Jacobo, P. V. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1995-5 · Cited by 52
Bioenergetics profile of CD4 + T cells in relapsing remitting multiple sclerosis subjects
Riccardis, L. D., Rizzello, A., Ferramosca, A., Urso, E., Robertis, F. D., Danieli, A., Giudetti, A. M., Trianni, G., Zara, V., & Maffia, M. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.02.015 · Cited by 53
Li, C., Zhao, P., Sun, X., Che, Y., & Jiang, Y. (2013) · Mediators of Inflammation · doi:10.1155/2013/639712 · Cited by 52
“Interestingly, IL-17A can disrupt the blood-brain barrier [32], and we found that the concentrations of CSF IL17A and IL-37 were correlated positively in those patients.”
BackgroundBlood–brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans
Mora, P., Hollier, P.-L., Guimbal, S., Abélanet, A., Diop, A., Cornuault, L., Couffinhal, T., Horng, S. H., Gadeau, A., Renault, M., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000946 · Cited by 58
“Noteworthy is the fact that down-regulation or reorganization of CLDNs and other tight junction proteins has been implicated in permeability in various tissues, particularly the gut [19,36,37]; however, reports of dynamic tight junction protein induction resulting in functional barrier formation have been rare [38,39].”
γδ T cells as early sensors of tissue damage and mediators of secondary neurodegeneration
Gelderblom, M., Arunachalam, P., & Magnus, T. U. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00368 · Cited by 60
“Several papers have shown a significant contribution of γδ T cells and IL-17 in stroke and other conditions of central nervous system inflammation (Kebir et al., 2007; Shichita et al., 2009; Caccamo et al., 2011; Gelderblom et al., 2012).”
Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients
Muls, N., Dang, H. A., Sindic, C. J. M., & Pesch, V. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113025 · Cited by 52
“The role of proinflammatory responses in MS has been largely investigated and the implication of the Th17 lineage has been demonstrated in animal and human studies [12–14].”
BackgroundIL17A-Mediated Endothelial Breach Promotes Metastasis Formation
Kulig, P., Burkhard, S., Mikita-Geoffroy, J., Croxford, A. L., Hövelmeyer, N., Gyülvészi, G., Gorzelanny, C., Waisman, A., Borsig, L., & Becher, B. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0154 · Cited by 54
“The receptors required to transduce IL17A signals, the IL17RA and IL17RC complex, are expressed predominantly by epithelial and endothelial cells (12, 13).”
BackgroundSelf-citationNeuromyelitis optica spectrum disorders and pregnancy: Interactions and management
Shosha, E., Pittock, S. J., Flanagan, E. P., & Weinshenker, B. G. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517740215 · Cited by 53
Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases
Li, Y., & Zhou, Y. (2019) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.247.87 · Cited by 55
“IL-17 could induce blood-brain barrier disruption, thereby participating in the development of inflammation of the central nervous system (Kebir et al. 2007; Huppert et al. 2010).”
BackgroundCharabati, M., Grasmuck, C., Ghannam, S., Bourbonnière, L., Fournier, A. P., Lécuyer, M., Tastet, O., Kébir, H., Rébillard, R., Hoornaert, C., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj0473 · Cited by 52
Self-citationGlial regulation of the blood-brain barrier in health and disease
Broux, B., Gowing, E., & Prat, A. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0516-2 · Cited by 57
Self-citationJunqueira, S. C., Coelho, I. D. S., Lieberknecht, V., Cunha, M. P., Calixto, J. Β., Rodrigues, A. L. S., Santos, A. R. S., & Dutra, R. C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9893-3 · Cited by 51
“These data are correlated to the involvement of IL-17 in Th17 infiltration across the BBB, thereby facilitating neuroinflammation and consequent CNS injury [59].”
BackgroundÁlvarez‐Sánchez, N., Cruz‐Chamorro, I., Díaz-Sánchez, M., Lardone, P. J., Guerrero, J. M., & Carrillo‐Vico, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-38897-w · Cited by 50
T Cells—Protective or Pathogenic in Alzheimer’s Disease?
McManus, R. M., Mills, K. H. G., & Lynch, M. A. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9612-2 · Cited by 54
“TNFα and IL-1β can reduce the TJ protein expression of vascular endothelial cells (Kebir et al. 2007; Minagar and Alexander 2003); these cytokines as well as IL-6, IL-18 and MCP-1 are increased in the circulation of AD patients (Akiyama et al. 2000; Brosseron et al. 2014).”
BackgroundTipping points in neurodegeneration
Simons, M., Levin, J., & Dichgans, M. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.031 · Cited by 50
The emerging role of aryl hydrocarbon receptor in the activation and differentiation of Th17 cells
Baricza, E., Tamási, V., Marton, N., Buzás, E. I., & Nagy, G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2056-2 · Cited by 58
Th17 lineage commitment and HIV-1 pathogenesis
Ancuța, P., Monteiro, P., & Sékaly, R. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283364733 · Cited by 59
TREK-King the Blood–Brain-Barrier
Bittner, S., Ruck, T., Fernández‐Orth, J., & Meuth, S. G. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9530-8 · Cited by 52
“This effect has been associated with a reduction of IL17-mediated BBB disruption (Huppert et al. 2010; Kebir et al. 2007), as Th17 cells have been associated with the downregulation of tight junction molecules.”
Borovčanin, M., Janicijevic, S. M., Jovanović, I., Gajović, N., Jurišević, M., & Arsenijević, N. (2020) · Diagnostics · doi:10.3390/diagnostics10110926 · Cited by 53
“It has been speculated that IL-17 affects tight junctions between endothelial cells in the blood–brain barrier, thus allowing Th17 cells, one of the main sources of IL-17, to enter easily and accumulate in the central nervous system (CNS) [30].”
Background
Metadata
- Authors
- Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A.
- Affiliations
- University of Zurich (CH)
- Hôpital Notre-Dame (CA)
- University of Alberta (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Nature Medicine
- Published
- 2007-09-09
- Volume
- 13
- Issue
- 10
- Pages
- 1173-1175
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC5114125
- OpenAlex
- W1998000193
- Semantic Scholar
- d0c491686d390e0dfdffedd4e32222d5b6065fd7
- Cited by
- 1,759
- References
- 14
- Citations by year
- 2026: 69 · 2025: 78 · 2024: 85 · 2023: 116 · 2022: 104 · 2021: 86 · 2020: 96 · 2019: 87 · 2018: 98 · 2017: 98 · 2016: 90 · 2015: 94 · 2014: 97 · 2013: 106 · 2012: 86
- FWCI
- 54.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (79785_1)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Th17 cells, blood-brain barrier, endothelial cells, IL-17, IL-22, tight junctions, multiple sclerosis, neuroinflammation, lymphocyte transmigration, granzyme B
- MeSH terms
- Blood-Brain Barrier, Cell Membrane Permeability, Cell Movement, Cells, Cultured, Central Nervous System, Dose-Response Relationship, Drug, Endothelium, Vascular, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Multiple Sclerosis, CD4-Positive T-Lymphocytes, Case-Control Studies, Receptors, Interleukin, Tight Junctions, Interleukin-17, Endothelial Cells, Granzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.